Back
Alnylam Pharmaceuticals Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
$251.26
Seasonality Move:
25.91%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
Alnylam Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 263.4 | Sell |
20-day SMA: | 249.93 | Buy |
50-day SMA: | 251.22 | Sell |
200-day SMA: | 259.09 | Sell |
8-day EMA: | 260.23 | Sell |
20-day EMA: | 255.26 | Sell |
50-day EMA: | 253.2 | Sell |
200-day EMA: | 245.77 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.09 | Buy |
Relative Strength Index (14 RSI): | 48.55 | Sell |
Chaikin Money Flow: | -547536 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (231.81 - 261.09) | Buy |
Bollinger Bands (100): | (237.33 - 268.25) | Sell |
Alnylam Pharmaceuticals Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 251.15 while ALNY 8-day simple moving average is 263.40, which is a Sell signal.
-
The stock price of ALNY is 251.15 while Alnylam Pharmaceuticals 20-day SMA is 249.93, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day simple moving average is 251.22 while ALNY share price is 251.15, making it a Sell technically.
-
ALNY stock price is 251.15 and Alnylam Pharmaceuticals 200-day simple moving average is 259.09, creating a Sell signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a SellThe current Alnylam Pharmaceuticals [ALNY] share price is $251.15. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
32.7B
Price in USD:
251.15
Share Volume:
656.4K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
144.73
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 251.15 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 251.15 while ALNY 8-day exponential moving average is 260.23, which is a Sell signal.
-
The stock price of ALNY is 251.15 while Alnylam Pharmaceuticals 20-day EMA is 255.26, which makes it a Sell.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 253.20 while ALNY share price is 251.15, making it a Sell technically.
-
ALNY stock price is 251.15 and Alnylam Pharmaceuticals 200-day simple moving average is 245.77, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $1.15 per share, an increase next quarter of $1.52 per share, an increase this year of $1.31 per share, and an increase next year of $2.89 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is 4.09, suggesting Alnylam Pharmaceuticals is a Buy
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 48.55, which suggest Alnylam Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (231.81 - 261.09), which suggest Alnylam Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (237.33 - 268.25), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.